These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19543652)

  • 1. [Osteonecrosis of the jaw secondary to oral alendronate: Report of three cases].
    Bocanegra-Pérez S; Vicente-Barrero M; Sosa-Henríquez M; Gebaguer Blanco A; Knezevic M; Castellano-Navarro JM
    Rev Med Chil; 2009 Feb; 137(2):275-9. PubMed ID: 19543652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of platelet-rich plasma in the management of oral biphosphonate-associated osteonecrosis of the jaw: a report of 2 cases.
    Lee CY; David T; Nishime M
    J Oral Implantol; 2007; 33(6):371-82. PubMed ID: 18240798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

  • 4. Is your knowledge up-to-date? Bisphosphonate-related osteonecrosis of the jaw.
    Barrow SY
    Int J Dent Hyg; 2008 Nov; 6(4):376-7. PubMed ID: 19138190
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
    Fedele S; Porter SR; D'Aiuto F; Aljohani S; Vescovi P; Manfredi M; Arduino PG; Broccoletti R; Musciotto A; Di Fede O; Lazarovici TS; Campisi G; Yarom N
    Am J Med; 2010 Nov; 123(11):1060-4. PubMed ID: 20851366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
    Gering A; Grange L; Villier C; Woeller A; Mallaret M
    Therapie; 2007; 62(1):49-54. PubMed ID: 17374348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.
    Lazarovici TS; Yahalom R; Taicher S; Elad S; Hardan I; Yarom N
    J Oral Maxillofac Surg; 2009 Apr; 67(4):850-5. PubMed ID: 19304045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosamax and osteonecrosis of the jaw--important questions and answers.
    Wynn RL
    Gen Dent; 2008; 56(4):315-7. PubMed ID: 19284187
    [No Abstract]   [Full Text] [Related]  

  • 10. Bisphosphonate-induced osteonecrosis of the jaw.
    Sharma V; Nagaraj S; Choksey U; Hegde A; Samant R; Balakrishnan C
    J Assoc Physicians India; 2011 Aug; 59():516-7. PubMed ID: 21887911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are there any alternatives to alendronate (Fosamax) for osteoporosis to avoid the risk of osteonecrosis of the jaw?
    Wynn RL
    Gen Dent; 2007; 55(6):495-8. PubMed ID: 18050572
    [No Abstract]   [Full Text] [Related]  

  • 13. A compounded diagnosis: maxillary osteochemonecrosis in the setting of low dose radiotherapy.
    Magliocca KR; Stavropoulos MF; Bhattacharyya I; Cohen DM
    J Oral Maxillofac Surg; 2009 May; 67(5):1138-40. PubMed ID: 19375031
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
    García Sáenz JA; López Tarruella S; García Paredes B; Rodríguez Lajusticia L; Villalobos L; Díaz Rubio E
    Med Oral Patol Oral Cir Bucal; 2007 Sep; 12(5):E351-6. PubMed ID: 17767097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates and oral pathology I. General and preventive aspects.
    Ponte Fernández N; Estefania Fresco R; Aguirre Urizar JM
    Med Oral Patol Oral Cir Bucal; 2006 Aug; 11(5):E396-400. PubMed ID: 16878067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of oral bisphosphonates: controlled studies on alveolar bone.
    Jeffcoat MK
    Int J Oral Maxillofac Implants; 2006; 21(3):349-53. PubMed ID: 16796276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.
    Bagan JV; Jimenez Y; Murillo J; Hernandez S; Poveda R; Sanchis JM; Diaz JM; Scully C
    Oral Oncol; 2006 Mar; 42(3):327-9. PubMed ID: 16275156
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings.
    Krishnan A; Arslanoglu A; Yildirm N; Silbergleit R; Aygun N
    J Comput Assist Tomogr; 2009; 33(2):298-304. PubMed ID: 19346864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between osteonecrosis of the jaws and chronic high-dosage intravenous bisphosphonates therapy.
    Graziani F; Cei S; La Ferla F; Cerri E; Itro A; Gabriele M
    J Craniofac Surg; 2006 Sep; 17(5):876-9. PubMed ID: 17003614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.